Clinical study demonstrates Oxiplex reduces leg pain and neurological symptoms following lumbar spine surgery. SAN LUIS OBISPO, California, March 10, 2026 — Fziomed, Inc. (“Fziomed” or the “Company”), a recognized global leader in postsurgical adhesion prevention with the best-in-class synthetic, absorbable gel technology platform, today announced results from a prospective, randomized, double-blinded, multi-center clinical study demonstrating […]

Best-in-class, synthetic, absorbable gel for use as an adjunct in lumbar spine surgery for the reduction of leg pain and neurological symptoms now available in the United States. SAN LUIS OBISPO, California, Nov. 5, 2025 — Fziomed, Inc. (“Fziomed” or the “Company”), a recognized global leader in postsurgical adhesion prevention with the best-in-class synthetic, absorbable […]